Abstract 14962: Empagliflozin’s Cardiovascular Impact in High-Risk Patients With Type 2 Diabetes and Obstructive Pulmonary Disease: An Inquiry From EMPA-REG OUTCOME

Stefan D Anker,David H Fitchett,Bernard Zinman,Anne Pernille Ofstad,Christoph Wanner,Ola Vedin,Birgit Schinzel,Henry K Yaggi,Jyothis T George,Leif Erik Sander,Silvio E Inzucchi,Subodh Verma

Circulation（2020）

引用 0|浏览8

暂无评分

摘要

Introduction: Type 2 diabetes (T2D) and chronic obstructive pulmonary disease (COPD) often co-exist yielding increased risk of cardiovascular (CV) complications, including heart failure (HF). In th...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要